🔎 Trials Near Me

Akèy › Skleroz Miltip › New Jersey

Etid klinik pou Skleroz Miltip nan New Jersey

11 etid pou Skleroz Miltip ap chèche patisipan nan sit nan New Jersey.

Vil nan New Jersey

Tèks ofisyèl etid la (Anglè)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Rutgers Cancer Institute of New Jersey, New Brunswick
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Bridgewater
  • TG Therapeutics Investigational Trial Site, Cherry Hill
  • TG Therapeutics Investigational Trial Site, Freehold
  • ak 3 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • Holy Name Medical Center- Site Number : 8400101, Teaneck
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 15, 2026 · NCT07325292

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  • Local Institution - 0131, New Brunswick
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Sep 10, 2026 · NCT06408259

A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice

  • Novartis, East Hanover
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Aug 21, 2026 · NCT07779460

A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis

  • Kessler Foundation, East Hanover
Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Aug 5, 2026 · NCT06197685

Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia

  • Bristol Myers Squibb, Lawrenceville
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 29, 2026 · NCT07732907

Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis

  • Atlantic Health, Morristown
Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou May 29, 2026 · NCT07614321

Multiple Sclerosis Implementation Network (Registry)

  • Multiple Sclerosis Association of America, Cherry Hill
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT07415824

Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

  • Kessler Foundation, West Orange
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Nov 24, 2025 · NCT04855825

Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the Community

  • Kessler Foundation, East Hanover
Ap rekrite
Laj 19 a 65 · Tout sèks · Mizajou Feb 21, 2025 · NCT06608797

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.